Burning Rock Biotech Limited (BNR) Misses Q3 EPS by 2c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of ($0.02). Revenue for the quarter came in at $18.49 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Putin, Xi, Trump may hold trilateral talks at APEC summit - Russia's Vesti
• MiniMed Group (MMED) PT Raised to $28 at BTIG
• DA Davidson Reiterates Underperform Rating on c3.ai (AI)